UB Paderborn / Katalog / Suche / in CDI

Commentary on “Sex and Gender Differences in Clinical Pharmacology: Implications for Transgender Medicine”

Clinical pharmacology and therapeutics, 2021-10, Vol.110 (4), p.863-865

Cotreau, Monette M.

2021

Link zum Volltext

Verfügbarkeit prüfen

The influence of age and sex on the clearance of cytochrome P450 3A substrates

Clinical pharmacokinetics, 2005, Vol.44 (1), p.33-60

2005

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway

Cancer research (Chicago, Ill.), 2009-08, Vol.69 (15), p.6171-6178

2009

Link zum Volltext

Verfügbarkeit prüfen

Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells

The Journal of molecular diagnostics : JMD, 2006-02, Vol.8 (1), p.51-61

2006

Link zum Volltext

Verfügbarkeit prüfen

Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor

Clinical pharmacology in drug development, 2015-03, Vol.4 (2), p.137-142

2015

Link zum Volltext

Verfügbarkeit prüfen

Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors

Clinical cancer research, 2011-11, Vol.17 (22), p.7156-7163

2011

Link zum Volltext

Verfügbarkeit prüfen

In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat

The Journal of pharmacology and experimental therapeutics, 2002-09, Vol.302 (3), p.1228

2002

Link zum Volltext

Verfügbarkeit prüfen

Developing antisense oligonucleotide and short-interfering RNA therapeutics - a few considerations

Clinical pharmacology in drug development, 2015-09, Vol.4 (5), p.323-325

Cotreau, Monette M.

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman

BMC medical genomics, 2008-06, Vol.1 (1), p.27-27, Article 27

2008

Link zum Volltext

Verfügbarkeit prüfen

The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans

Journal of clinical pharmacology, 2003-10, Vol.43 (10), p.1108-1115

2003

Link zum Volltext

Verfügbarkeit prüfen

Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(−/−) mouse liver microsomes

Biochemical pharmacology, 1999-06, Vol.57 (11), p.1227-1232

1999

Link zum Volltext

Verfügbarkeit prüfen

Dose-Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans

Journal of clinical pharmacology, 1997-08, Vol.37 (8), p.693-703

1997

Link zum Volltext

Verfügbarkeit prüfen

Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level

Journal of pharmacological and toxicological methods, 2000-01, Vol.43 (1), p.41-54

2000

Link zum Volltext

Verfügbarkeit prüfen

The effect of food on the pharmacokinetics of tivozanib hydrochloride

Clinical pharmacology in drug development, 2014-03, Vol.3 (2), p.158-162

2014

Link zum Volltext

Verfügbarkeit prüfen

A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors

Clinical pharmacology in drug development, 2014-07, Vol.3 (4), p.284-289

2014

Link zum Volltext

Verfügbarkeit prüfen

A study of 17β-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy

Maturitas, 2007-12, Vol.58 (4), p.366-376

2007

Link zum Volltext

Verfügbarkeit prüfen

Absorption, Metabolism, and Excretion of [14C]-Tivozanib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Male Participants: A Phase I, Open-Label, Mass-Balance Study

Clinical pharmacology in drug development, 2012-07, Vol.1 (3), p.102-109

2012

Link zum Volltext

Verfügbarkeit prüfen

A multiple-dose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin)

Biopharmaceutics & drug disposition, 2004-10, Vol.25 (7), p.291-296

2004

Link zum Volltext

Verfügbarkeit prüfen

Fluoxetine impairs clearance of alprazolam but not of clonazepam

Clinical pharmacology and therapeutics, 1992-11, Vol.52 (5), p.479-486

1992

Link zum Volltext

Verfügbarkeit prüfen

Multiple-Dose, Safety, Pharmacokinetics, and Pharmacodynamics of a New Selective Estrogen Receptor Modulator, ERA-923, in Healthy Postmenopausal Women

Journal of clinical pharmacology, 2002-02, Vol.42 (2), p.157-165

2002

Link zum Volltext

Verfügbarkeit prüfen

A Single Administration of Recombinant Human Interleukin-12 Is Associated With Increased Expression Levels of Interferon-gamma and Signal Transducer and Activator of Transcription in Healthy Subjects

Journal of clinical pharmacology, 2005-06, Vol.45 (6), p.649-658

2005

Link zum Volltext

Verfügbarkeit prüfen

Abstract 752: The effect of food on the pharmacokinetics of tivozanib

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.752-752

2012

Link zum Volltext

Verfügbarkeit prüfen

Effects of benzodiazepine administration on A1 adenosine receptor binding in-vivo and ex-vivo

Journal of pharmacy and pharmacology, 1992-08, Vol.44 (8), p.700-703

1992

Link zum Volltext

Verfügbarkeit prüfen

Unusually Low Clearance of Two CYP3A Substrates, Alprazolam and Trazodone, in a Volunteer Subject with Wild‐Type CYP3A4 Promoter Region

Journal of clinical pharmacology, 2000-02, Vol.40 (2), p.200-204

2000

Link zum Volltext

Verfügbarkeit prüfen

Molecular and Pharmacokinetic Evaluation of Rat Hepatic and Gastrointestinal Cytochrome P450 Induction by Tamoxifen

Pharmacology, 2001-01, Vol.63 (4), p.210-219

2001

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Commentary on “Sex and Gender Differences in Clinical Pharmacology: Implications for Transgender Medicine”

The influence of age and sex on the clearance of cytochrome P450 3A substrates

Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway

Molecular Classification of Crohn's Disease and Ulcerative Colitis Patients Using Transcriptional Profiles in Peripheral Blood Mononuclear Cells

Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor

Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors

In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat

Developing antisense oligonucleotide and short-interfering RNA therapeutics - a few considerations

Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal woman

The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans

Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(−/−) mouse liver microsomes

Dose-Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans

Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level

The effect of food on the pharmacokinetics of tivozanib hydrochloride

A Phase I cardiac safety and pharmacokinetic study of tivozanib hydrochloride in patients with advanced solid tumors

A study of 17β-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy

Absorption, Metabolism, and Excretion of [14C]-Tivozanib, a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Male Participants: A Phase I, Open-Label, Mass-Balance Study

A multiple-dose, safety, tolerability, pharmacokinetics and pharmacodynamic study of oral recombinant human interleukin-11 (oprelvekin)

Fluoxetine impairs clearance of alprazolam but not of clonazepam

Multiple-Dose, Safety, Pharmacokinetics, and Pharmacodynamics of a New Selective Estrogen Receptor Modulator, ERA-923, in Healthy Postmenopausal Women

A Single Administration of Recombinant Human Interleukin-12 Is Associated With Increased Expression Levels of Interferon-gamma and Signal Transducer and Activator of Transcription in Healthy Subjects

Abstract 752: The effect of food on the pharmacokinetics of tivozanib

Effects of benzodiazepine administration on A1 adenosine receptor binding in-vivo and ex-vivo

Unusually Low Clearance of Two CYP3A Substrates, Alprazolam and Trazodone, in a Volunteer Subject with Wild‐Type CYP3A4 Promoter Region

Molecular and Pharmacokinetic Evaluation of Rat Hepatic and Gastrointestinal Cytochrome P450 Induction by Tamoxifen

Suchergebnisse filtern